Rebirth of Hong Kong 1981

But the experiment cannot be based on a single case, it needs huge data support, one in a million, one in ten million...

This cost is very unbearable for any pharmaceutical company.

And it just so happened that our third brother carried forward the spirit of fearlessness and self-sacrifice, stepped forward and opened his heart to pharmaceutical companies all over the world.

He expressed his willingness to exchange more than one billion mice in exchange for the production authorization of patented drugs.

Because of this, pharmaceutical companies all over the world have turned a blind eye to generic drugs in India.

After all, they all carry forward the spirit of fearless dedication and test new drugs for everyone for free, so it should be taken advantage of.

Yang Chen expressed his sincere admiration for Brother Ah San's spirit in this aspect. He really couldn't learn this aspect. He didn't have the spirit of self-sacrifice and dedication, so he should give some money.

Yang Chen said it was acceptable.

Chapter 715 Small Target: General Agent

In the next two days, while Yang Chen inspected the work situation of the American company, he also took time to participate in the board of directors of all shareholders of Shire Company initiated by the old Jack.

He can learn from the island country for Chinese medicine, but there is obviously no way for this western medicine. He has to rely on pharmaceutical companies in Europe and the United States such as the United States.

Shire Company is his first step into Western medicine. As long as the board of directors approves it, then relying on the strength of Shire Company can completely help him establish a modern and first-class pharmaceutical production factory in Xiangjiang.

Affected by the overall environment of the pharmaceutical industry, Shire's shareholders are still interested in entering the Asian market.

If you are not interested, there is nothing you can do. The proposal was put forward by Yang Chen, the company's third largest shareholder, and Old Jack, the largest shareholder and chairman, agreed.

Therefore, the other directors of the board of directors did not object to Yang Chen's proposal.

Even Shire's second largest shareholder has not expressed any objection to the company's plan to open a branch in Asia.

This is thanks to Yang Chen's money offensive, the establishment of the Asian branch, Shire's head office only needs to send out people, prescriptions and other free work, and all other expenses are all paid by Yang Chen, a good money winner. Responsible.

Shire's head office occupies 40.00% of the shares of the Asian branch without paying a penny. This kind of cheapness is not for nothing.

Of course, this is just one of the reasons.

The reason why everyone really accepted Yang Chen's holding of the branch company and having the final pricing power is that most shareholders don't pay much attention to the current Asian market.

Although the population of Asia has a great advantage, it is still in the initial stage of development after all. Many developing countries have never really paid much attention to drug patents.

It is simply not feasible to sell high-priced medicines. You can only choose small profits but quick sales.

Except for Asian countries with rapid economic development such as island countries and South Korea, most Asian countries have not done a good job in the protection of pharmaceutical patents even in the 21st century.

The general direction of the majority of Shire's shareholders is mainly to focus on the US domestic market, as well as developed countries such as Europe and countries with sound systems.

If Yang Chen wants to obtain the final pricing power in the markets of developed countries, there is no door, so there is no need to even think about it, not to mention that the shareholders will not agree, I am afraid that even Old Jack will not agree.

"Boss, Manager Shen is here."

"boss"

Although it wasn't the first time for Shen Xu to meet Yang Chen, it was the first time for him to meet in private like this, especially two days ago, Orange Technology was successfully listed in the United States, which made Yang Chen's worth skyrocket.

Facing the newly promoted richest man in Chinese, the big boss who rewarded him with his job, Shen Xu dared not show any disrespect.

"Sit down, don't stand up."

"Thank you boss"

Regardless of Shen Xu's cautious appearance, Huo Jianxuan took out a contract from his briefcase and handed it to Yang Chen.

"Boss, I persuaded several small shareholders of Shire Company to buy out the [-]% shares of Shire Company they held.

From now on, we have held 20.00% of Shire's shares.

This is an equity transfer contract. The shares we hold have surpassed that of Mr. Ness (the former second shareholder of Shire). If the shares held by Chairman Jack are added, the shares held by the two of us in Shire Already more than half.

In the next round of financing and stock expansion, I think that Mr. Jack will definitely not reduce his shareholding. At that time, as long as we continue to absorb Shire’s shares and keep the shares we hold from falling below 20.00%, we will be able to ensure the success of the Asian branch in the future. built. "

Yang Chen took the equity transfer letter handed over by Huo Jianxie, glanced at it, then handed it to Shen Xu who was sitting upright, and said, "Manager Shen, I think Manager Huo is on the way and has already told you about the matter. say clearly.

This time you have been transferred from Chengzi Technology to take charge of this matter. I hope you can handle it well.Next, I will notify the Shire company, and you will handle the corresponding affairs on my behalf.

In addition to ensuring that the shares we hold will not drop during the financing process, there is also the need to urge the Shire head office to speed up. "

"If there is a chance, I hope you can persuade Shire's shareholders for me to move Shire's pharmaceutical factory to Asia."

"Of course, this matter cannot be rushed, and there will definitely be no results in a short time, but as the labor costs in the United States continue to rise, many American companies have begun to relocate their factories out of the United States.

And the U.S. government also intends to outsource these factories. We can wait for the opportunity slowly. As long as the opportunity comes, you must seize it. If it doesn’t work, just call me. "

Seeing Yang Chen's serious face, Shen Xu obviously attached great importance to this matter, and he also took it seriously.

Without waiting for Shen Xu to speak, Yang Chen continued: "By the way, after the branch office in Asia is completed, you need to go to the American Medical University to help the company recruit some top medical talents. We can't just produce , instead of researching new drugs..."

For a long time, Yang Chen knew a truth.

That is, what belongs to others is always someone else's, and some things belong to oneself only when one has mastered them.

The world has never lacked cases of counterattacks by small people. For the same reason, branch companies are not necessarily worse than the head office.

As long as he is willing to invest, it is not a fantasy to be on an equal footing with Shire head office in the future with the entire Asian market.

Shire is not a leading company in the U.S. pharmaceutical industry. It is only among the pharmaceutical companies and ranks relatively high. There are still many excellent pharmaceutical companies in the U.S., and Shire will face great competitive pressure in the future.

But Yang Chen's side is different. The entire Asian market is still being cultivated. Compared with the American market, the competitive pressure will be much less.

One goes up and down, and he has no pressure on the counterattack of the branch.

Furthermore, he still holds stocks in other American pharmaceutical companies. As long as he works well, he can become the general agent of American pharmaceutical companies in Asia.

Of course, a small agency.It will definitely not satisfy his appetite, even if this agent has the drug pricing power and production chain.

His goal is to establish a top pharmaceutical research institute in the world, so as to compete with the top pharmaceutical companies in the world in the future.

In other words, he hopes that his future pharmaceutical company can contribute to the benefit of all mankind.

Ahem, well, those things are still too far away.

It cannot be completed overnight.

Now let’s be more realistic, first set a small goal, build a pharmaceutical factory, and get the title of general agent.

Chapter 716 Invitation from the Chinese Chamber of Commerce

After instructing Shen Xu, Yang Chen let him go out.